-
Mashup Score: 1ACP Internist - 4 month(s) ago
ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.
Source: www.acpinternist.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 5ACP Internist - 5 month(s) ago
ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.
Source: www.acpinternist.orgCategories: General Medicine News, General Journals & SocietTweet-
Some of the latest in @acpinternist for September: https://t.co/fFr6TUpGqL 🔸 Swallowing gone wrong in EoE 🔸 Mitigate potential workplace violence 🔸 Washington Perspective: Preparing today for tomorrow's potential pandemic https://t.co/ZrUANSg9X1
-
-
Mashup Score: 1ACP Internist - 5 month(s) ago
ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.
Source: www.acpinternist.orgCategories: General Medicine News, General Journals & SocietTweet-
Read some of the latest in ACP Internist Weekly: https://t.co/3FYNzFKT4k 🔸 SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout 🔸 Phase 3 trial shows efficacy of donanemab for Alzheimer disease https://t.co/6HRirPKfy0
-
-
Mashup Score: 1ACP Internist - 5 month(s) ago
ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.
Source: www.acpinternist.orgCategories: General Medicine News, General Journals & SocietTweet-
Read some of the latest in ACP Internist Weekly: https://t.co/3FYNzFKT4k 🔸 SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout 🔸 Phase 3 trial shows efficacy of donanemab for Alzheimer disease https://t.co/6HRirPKfy0
-
-
Mashup Score: 1ACP Internist - 6 month(s) ago
ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.
Source: www.acpinternist.orgCategories: General Medicine News, General Journals & SocietTweet-
Read some of the latest in ACP Internist Weekly: https://t.co/3FYNzFKT4k 🔸 SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout 🔸 Phase 3 trial shows efficacy of donanemab for Alzheimer disease https://t.co/6HRirPKfy0
-
-
Mashup Score: 1ACP Internist - 6 month(s) ago
ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.
Source: www.acpinternist.orgCategories: General Medicine News, General Journals & SocietTweet-
Read some of the latest in ACP Internist Weekly: https://t.co/3FYNzFKT4k 🔸 SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout 🔸 Phase 3 trial shows efficacy of donanemab for Alzheimer disease https://t.co/6HRirPKfy0
-
-
Mashup Score: 4ACP Internist - 6 month(s) ago
ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.
Source: www.acpinternist.orgCategories: General Medicine News, General Journals & SocietTweet-
Some of the latest in @acpinternist for September: https://t.co/fFr6TUpGqL 🔸 Swallowing gone wrong in EoE 🔸 Mitigate potential workplace violence 🔸 Washington Perspective: Preparing today for tomorrow's potential pandemic https://t.co/ZrUANSg9X1
-
-
Mashup Score: 1ACP Internist - 6 month(s) ago
ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.
Source: www.acpinternist.orgCategories: General Medicine News, General Journals & SocietTweet-
Read some of the latest in ACP Internist Weekly: https://t.co/3FYNzFKT4k 🔸 SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout 🔸 Phase 3 trial shows efficacy of donanemab for Alzheimer disease https://t.co/6HRirPKfy0
-
-
Mashup Score: 0ACP Internist - 6 month(s) ago
ACP Internist provides news and information for internal medicine physicians about the practice of medicine and reports on the policies, products, and activities of ACP.
Source: www.acpinternist.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Read some of the latest in @acpinternist Weekly: https://t.co/3FYNzFKT4k 🔸 Guidance issued on outpatient testing for fungal infections in CAP 🔸 Routine opioid use disorder screening fails to significantly increase new diagnosis rates https://t.co/3xDjuL5NFR
-
-
Mashup Score: 0College governance - 7 month(s) ago
Initiating a resolution provides members an opportunity to focus attention at the national level on a particular issue or topic that concerns them. The deadline for submitting new resolutions to be heard at the spring 2024 Board of Governors meeting is Oct. 16.
Source: www.acpinternist.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Are you concerned about a practice or clinical issue? Consider submitting a resolution to your Governor or chapter council. The deadline for submitting new resolutions to be heard at the spring 2024 Board of Governors meeting is October 16, 2023: https://t.co/Q0y2G8CG4L https://t.co/lLzGlhMEP1
-
Read some of the latest in ACP Internist Weekly: https://t.co/3FYNzFKT4k 🔸 SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout 🔸 Phase 3 trial shows efficacy of donanemab for Alzheimer disease https://t.co/6HRirPKfy0